pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

Senate finance and health committees brace for major Republican turnover ahead of midterms

Oct 1, 2026·read at STAT ↗Neutral

The upcoming midterm elections are set to trigger substantial changes to two Senate committees that oversee health‑care policy.

The Senate Finance Committee could see at least five of its 14 Republican members leave, creating a notable shift in its partisan balance.

The Health Committee also anticipates turnover among GOP senators, though the exact numbers are not detailed, potentially reshaping its policy focus.

Should Democrats capture control of the Senate, they will assume leadership of both panels, yet the Republican departures will still affect the committees' direction.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Two key Senate health committees face major shake-ups”

read at STAT ↗
469 words · retrieved 7m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoOpinion: Claude analyzed my genome in 30 minutes. Now we need standards for the resultsSTAT
  • 1h agoOpinion: I studied GLP-1 use in children. The results are reassuringSTAT
  • 1h agoSTAT+: Can a top Republican from a bygone political era fix pharma’s woes in Washington?STAT
  • 1h agoSTAT+: In Shanghai’s ‘Science City,’ China’s ascendant biotechs make their pitch to the worldSTAT
  • 3h agoSTAT+: Sanofi, Regeneron expand partnership after Dupixent successSTAT